Olon, a pharmaceutical manufacturing company, has announced the completion of the VI Mod-6 project, which has increased the production capacity of its manufacturing facility in India by approximately 25%.
The project included the installation of advanced equipment capable of conducting large-scale cryogenic and nBuLi (n-butyllithium) reactions. These processes are designed to meet stringent safety and environmental standards while enabling high technical performance.
According to the company, the project involved equipment procurement, engineering development, installation, commissioning, and final qualification. The facility was successfully qualified in September 2024.
The expansion underscores Olon’s efforts to enhance its operational capabilities at the site, focusing on high-performance chemical processes.